ID
EN
Tahun
-
Monday, 5 October 2026Download
Bio Farma Receives Trusted and Popular Brand 2026 Award, Strengthening Public Trust through Quality and Healthcare Innovation
-
Thursday, 1 October 2026Download
Bio Farma Group Strengthens National Health Resilience through Global Collaboration on Influenza Antiviral Development
-
Wednesday, 30 September 2026Download
Bio Farma Engages Employees in Technology-Driven Mangrove Conservation Innovation in Karawang
-
Wednesday, 30 September 2026Download
Bio Farma Strengthens Indonesia–Ghana Collaboration to Build Health Security through Vaccine Technology Transfer
-
Friday, 25 September 2026Download
Bio Farma Highlights Vaccine Manufacturing as Strategic Infrastructure for Global Health Security
-
Friday, 25 September 2026Download
Bio Farma and DWP Central Expand Access to HPV Vaccination Through DWP Sehat Program
-
Thursday, 24 September 2026Download
Bio Farma and MSD Expand Strategic Partnership to Strengthen Local Vaccine Manufacturing Capabilities
-
Tuesday, 15 September 2026Download
Bio Farma Achieves 100% in 2026 WHO Accreditation Assessment, Affirming Measles and Rubella Laboratory Competence
-
Friday, 11 September 2026Download
Bio Farma Wins Indonesia Most Reputable Companies Award 2026, Reinforcing Reputation Built on Capability and Trust
-
Thursday, 3 September 2026Download
Bio-RV, a Neonatal Rotavirus Vaccine Developed Through Bio Farma–MCRI Collaboration, Receives Marketing Authorization from the Indonesian Food and Drug Authority, BPOM